Ralph Niven - CHIEF SCIENTIFIC OFFICER at Jade Biosciences, Inc.

Issuer-level insider activity

Role
Chief Scientific Officer
Issuer ticker
JBIO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Ralph Niven since 05 Sep 2025

Reported holdings for Ralph Niven in Jade Biosciences, Inc.

Form 4 holding CHIEF SCIENTIFIC OFFICER

Aerovate Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
41,732
Estimated value
$562,965
Report date
05 Feb 2024
Price
$13.49
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF SCIENTIFIC OFFICER

Aerovate Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,609
Estimated value
$28,070
Report date
05 Feb 2024
Price
$17.45
Ownership
Direct

Transaction history for Ralph Niven in Jade Biosciences, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .